NetworkNewsBreaks

ThursdayJun 03, 2021 9:39 am

NetworkNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Announces NASDAQ Notification of Delayed Filing of Quarterly Report

Trident Acquisitions (NASDAQ: TDAC, TDACU, TDACW) announced that it had received a standard notice last month from the listing qualifications staff of the Nasdaq Stock Market LLC. The notice stated that TDAC is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies to file all required periodic financial reports with the Securities Exchange Commission (“SEC”) in a timely manner. TDAC was notified that the company hadn’t filed its quarterly report for the period ending March 31, 2021. The company also noted that in April, the SEC issued a statement providing guidance for all SPAC-related companies regarding the accounting and…

Continue Reading

WednesdayJun 02, 2021 1:39 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

CNS Pharmaceuticals (NASDAQ: CNSP) is focused on producing a treatment that improves on the effectiveness of established chemotherapy drug lomustine in increasing overall survival rates of glioblastoma multiforme (“GBM”) patients. GBM is an illness that is nearly 100% fatal in patients just over a year after diagnosis. CNS Pharmaceuticals’ lead drug candidate, Berubicin, has been granted investigational new drug (“IND”) status after promising findings. “Berubicin is a standout anthracycline therapy because of its novel apparent ability to cross the blood-brain barrier to combat neurological tumors. The drug was the subject of a Phase I trial some 15 years ago in…

Continue Reading

WednesdayJun 02, 2021 1:30 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, continues to create value for a growing customer base through its subsidiaries. Researchers from one such subsidiary, Helomics, recently completed key sequencing milestones for ovarian cancer to help build its AI-driven models of the disease. “We are building a strong commercial pipeline for our unique Patient-cEntric Discovery by Active Learning (PeDAL)(TM), which we launched at the beginning of 2021,” POAI CEO J. Melville Engle was quoted in a recent article. “PeDAL brings together the key Helomics assets of real-world longitudinal data…

Continue Reading

WednesdayJun 02, 2021 12:58 pm

NetworkNewsBreaks – Perpetual Industries Inc. (PRPI) Featured in Video Interview as Incubator of Innovation, Bringing Bright Ideas to Life

Perpetual Industries’ (OTC: PRPI) CEO Brent Bedford was featured in a recent video interview where he provided an overview of PRPI’s business strategy and a closer look at two projects the company is involved in. “PRPI is designed to be an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale,” reads a recent article discussing the company. “Everybody knows somebody that is a crazy inventor out there, right?” said Bedford during the video interview, now available on the company’s YouTube…

Continue Reading

WednesdayJun 02, 2021 12:22 pm

NetworkNewsBreaks – Cognos Therapeutics Corp. Signs Agreement to Work with Maxim Group LLC for Investment Banking, Financial Advisory Services

Cognos Therapeutics Corp., an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, has signed a letter of engagement with Maxim Group LLC. According to the agreement, Maxim will provide financial advisory and investment banking services to Cognos; the services will also include support in identifying and evaluating merger and acquisition opportunities. “We are incredibly pleased to launch this relationship with Maxim,” said Cognos CEO Frank Adell in the press release. “We believe Maxim can assist us in pursuing strategic growth and in building long-term value for our shareholders. . .…

Continue Reading

WednesdayJun 02, 2021 12:09 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Releases Financial Results for FYE 2021

FingerMotion (OTCQX: FNGR), a mobile services and data company, has released its financial results for the fiscal year ending Feb. 28, 2021. A highlight of the report was record annual revenue of $16.68 million, which includes the company’s SMS (“SMS”) & MMS (“MMS”) and telecommunications products and services. That total represents an estimated 82% increase from FYE 2020. Other financial numbers worth noting include annual growth in SMS & MMS business revenue of $6.13 million, or 84% compared to the same period the year before; annual growth in telecommunications products and services business revenue of $1.39 million, or a 76%…

Continue Reading

WednesdayJun 02, 2021 12:07 pm

NetworkNewsBreaks – Finovate Announces Deadline to Nominate Companies and Individuals Driving Fintech Innovation, New Ideas

Finovate, a leading fintech event series and digital engagement platform, has announced the June 11 nomination deadline for companies looking to take part in the 2021 edition of the Finovate Awards. The awards recognize companies driving fintech innovation forward and individuals bringing new ideas to life. Leading banks, fintech firms, accelerators, innovators, and executives will compete in 25 different categories that represent the multitude of ways technology is revolutionizing the financial ecosystem. “It is always important to recognize the dedication and effort that goes into bringing successful fintech solutions to the market, but it’s especially vital this year,” said Greg…

Continue Reading

WednesdayJun 02, 2021 12:01 pm

NetworkNewsBreaks – Chalice Brands Ltd. (CSE: CHAL) (OTCQB: GLDFF) Announces OTC Ticker Symbol Change Effective June 3, 2021

Chalice Brands (CSE: CHAL) (OTCQB: GLDFF), formerly Golden Leaf Holdings Ltd., a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announced a change in the company's stock symbol trading on the OTCQB(R) Venture Market. According to the update, the company's common shares will trade on the OTCQB under the symbol "CHALF" effective June 3, 2021. The previous trading symbol was "GLDFF." To view the full press release, visit https://nnw.fm/BC2ue About Chalice Brands Ltd. Chalice Brands is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution, and retail, with 12 dispensaries in Portland, Oregon.…

Continue Reading

WednesdayJun 02, 2021 11:51 am

NetworkNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Sees Stellar Month Prior to Unveiling Several New Features

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced certain performance and growth metrics for its Fan Pass livestreaming artist platform for the month of May 2021. According to the update, May has delivered another stellar month of traction in several categories as the company prepares to release its 2.0 version of the Fan Pass platform. “These next several months are going to lead us to and eventually through our version 2 mobile and web app releases, which will include an entirely new suite of features, virtual currency options, automation and, ultimately, scale,” said Friendable CEO Robert A.…

Continue Reading

WednesdayJun 02, 2021 11:45 am

NetworkNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) to Present at Upcoming H.C. Wainwright Psychedelics Conference

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, has announced that it will be presenting at H.C. Wainwright & Co.’s Psychedelics in Psychiatry and Beyond conference. The virtual event will be held on June 17, 2021. At the elite conference, Tryp chair and CEO Greg McKee will present an overview of the business including the company’s pipeline, which features its psilocybin-for-neuropsychiatric disorders, or PFN(TM) (“PFN”), program for chronic pain and eating disorder indications. McKee’s prerecorded presentation will be available beginning 7 a.m. EDT…

Continue Reading